pharmaceuticals-and-healthcare

Global Neurological Biomarkers Sales Market Report 2017


Published On : Jul 2017

Category : Pharmaceutical

No. of Pages : 117 pages

  • $4000
  • $8000

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
Table of Contents

Global Neurological Biomarkers Sales Market Report 2017
1 Neurological Biomarkers Market Overview
1.1 Product Overview and Scope of Neurological Biomarkers
1.2 Classification of Neurological Biomarkers by Product Category
1.2.1 Global Neurological Biomarkers Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Neurological Biomarkers Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Alzheimer's Disease
1.2.4 Parkinson's Disease
1.2.5 Autism Spectrum Disorder
1.2.6 Multiple Sclerosis
1.2.7 Other
1.3 Global Neurological Biomarkers Market by Application/End Users
1.3.1 Global Neurological Biomarkers Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Genomics
1.3.3 Proteomics
1.3.4 Metabolomics
1.3.5 Imaging
1.3.6 Other
1.4 Global Neurological Biomarkers Market by Region
1.4.1 Global Neurological Biomarkers Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Neurological Biomarkers Status and Prospect (2012-2022)
1.4.3 China Neurological Biomarkers Status and Prospect (2012-2022)
1.4.4 Europe Neurological Biomarkers Status and Prospect (2012-2022)
1.4.5 Japan Neurological Biomarkers Status and Prospect (2012-2022)
1.4.6 Southeast Asia Neurological Biomarkers Status and Prospect (2012-2022)
1.4.7 India Neurological Biomarkers Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Neurological Biomarkers (2012-2022)
1.5.1 Global Neurological Biomarkers Sales and Growth Rate (2012-2022)
1.5.2 Global Neurological Biomarkers Revenue and Growth Rate (2012-2022)

2 Global Neurological Biomarkers Competition by Players/Suppliers, Type and Application
2.1 Global Neurological Biomarkers Market Competition by Players/Suppliers
2.1.1 Global Neurological Biomarkers Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Neurological Biomarkers Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Neurological Biomarkers (Volume and Value) by Type
2.2.1 Global Neurological Biomarkers Sales and Market Share by Type (2012-2017)
2.2.2 Global Neurological Biomarkers Revenue and Market Share by Type (2012-2017)
2.3 Global Neurological Biomarkers (Volume and Value) by Region
2.3.1 Global Neurological Biomarkers Sales and Market Share by Region (2012-2017)
2.3.2 Global Neurological Biomarkers Revenue and Market Share by Region (2012-2017)
2.4 Global Neurological Biomarkers (Volume) by Application

3 United States Neurological Biomarkers (Volume, Value and Sales Price)
3.1 United States Neurological Biomarkers Sales and Value (2012-2017)
3.1.1 United States Neurological Biomarkers Sales and Growth Rate (2012-2017)
3.1.2 United States Neurological Biomarkers Revenue and Growth Rate (2012-2017)
3.1.3 United States Neurological Biomarkers Sales Price Trend (2012-2017)
3.2 United States Neurological Biomarkers Sales Volume and Market Share by Players
3.3 United States Neurological Biomarkers Sales Volume and Market Share by Type
3.4 United States Neurological Biomarkers Sales Volume and Market Share by Application

4 China Neurological Biomarkers (Volume, Value and Sales Price)
4.1 China Neurological Biomarkers Sales and Value (2012-2017)
4.1.1 China Neurological Biomarkers Sales and Growth Rate (2012-2017)
4.1.2 China Neurological Biomarkers Revenue and Growth Rate (2012-2017)
4.1.3 China Neurological Biomarkers Sales Price Trend (2012-2017)
4.2 China Neurological Biomarkers Sales Volume and Market Share by Players
4.3 China Neurological Biomarkers Sales Volume and Market Share by Type
4.4 China Neurological Biomarkers Sales Volume and Market Share by Application

5 Europe Neurological Biomarkers (Volume, Value and Sales Price)
5.1 Europe Neurological Biomarkers Sales and Value (2012-2017)
5.1.1 Europe Neurological Biomarkers Sales and Growth Rate (2012-2017)
5.1.2 Europe Neurological Biomarkers Revenue and Growth Rate (2012-2017)
5.1.3 Europe Neurological Biomarkers Sales Price Trend (2012-2017)
5.2 Europe Neurological Biomarkers Sales Volume and Market Share by Players
5.3 Europe Neurological Biomarkers Sales Volume and Market Share by Type
5.4 Europe Neurological Biomarkers Sales Volume and Market Share by Application

6 Japan Neurological Biomarkers (Volume, Value and Sales Price)
6.1 Japan Neurological Biomarkers Sales and Value (2012-2017)
6.1.1 Japan Neurological Biomarkers Sales and Growth Rate (2012-2017)
6.1.2 Japan Neurological Biomarkers Revenue and Growth Rate (2012-2017)
6.1.3 Japan Neurological Biomarkers Sales Price Trend (2012-2017)
6.2 Japan Neurological Biomarkers Sales Volume and Market Share by Players
6.3 Japan Neurological Biomarkers Sales Volume and Market Share by Type
6.4 Japan Neurological Biomarkers Sales Volume and Market Share by Application

7 Southeast Asia Neurological Biomarkers (Volume, Value and Sales Price)
7.1 Southeast Asia Neurological Biomarkers Sales and Value (2012-2017)
7.1.1 Southeast Asia Neurological Biomarkers Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Neurological Biomarkers Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Neurological Biomarkers Sales Price Trend (2012-2017)
7.2 Southeast Asia Neurological Biomarkers Sales Volume and Market Share by Players
7.3 Southeast Asia Neurological Biomarkers Sales Volume and Market Share by Type
7.4 Southeast Asia Neurological Biomarkers Sales Volume and Market Share by Application

8 India Neurological Biomarkers (Volume, Value and Sales Price)
8.1 India Neurological Biomarkers Sales and Value (2012-2017)
8.1.1 India Neurological Biomarkers Sales and Growth Rate (2012-2017)
8.1.2 India Neurological Biomarkers Revenue and Growth Rate (2012-2017)
8.1.3 India Neurological Biomarkers Sales Price Trend (2012-2017)
8.2 India Neurological Biomarkers Sales Volume and Market Share by Players
8.3 India Neurological Biomarkers Sales Volume and Market Share by Type
8.4 India Neurological Biomarkers Sales Volume and Market Share by Application

9 Global Neurological Biomarkers Players/Suppliers Profiles and Sales Data
9.1 Thermo Fisher Scientific (U.S.)
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Neurological Biomarkers Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Qiagen (Germany)
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Neurological Biomarkers Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Qiagen (Germany) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Myriad RBM (U.S.)
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Neurological Biomarkers Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Myriad RBM (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Proteome Sciences (UK)
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Neurological Biomarkers Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Proteome Sciences (UK) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Banyan Biomarkers (U.S.)
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Neurological Biomarkers Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Banyan Biomarkers (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Cisbio Bioassays (U.S.)
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Neurological Biomarkers Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Cisbio Bioassays (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Abiant (U.S.)
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Neurological Biomarkers Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Abiant (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Acumen Pharmaceuticals (U.S.)
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Neurological Biomarkers Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Proteosys (Germany)
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Neurological Biomarkers Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Proteosys (Germany) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Alseres Pharmaceuticals (U.S.)
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Neurological Biomarkers Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Athena Diagnostics (U.S.)

10 Neurological Biomarkers Maufacturing Cost Analysis
10.1 Neurological Biomarkers Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Neurological Biomarkers
10.3 Manufacturing Process Analysis of Neurological Biomarkers

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Neurological Biomarkers Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Neurological Biomarkers Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Neurological Biomarkers Market Forecast (2017-2022)
14.1 Global Neurological Biomarkers Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Neurological Biomarkers Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Neurological Biomarkers Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Neurological Biomarkers Price and Trend Forecast (2017-2022)
14.2 Global Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Neurological Biomarkers Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Neurological Biomarkers Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Neurological Biomarkers Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Neurological Biomarkers Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Neurological Biomarkers Sales Forecast by Type (2017-2022)
14.3.2 Global Neurological Biomarkers Revenue Forecast by Type (2017-2022)
14.3.3 Global Neurological Biomarkers Price Forecast by Type (2017-2022)
14.4 Global Neurological Biomarkers Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


Back To Top